Skip to Main Content
Skip Nav Destination

This chapter shows how evidence from clinical trials emerges, how those findings determine insurance reimbursement patterns and then treatment standards, and how those organize the work of doctors. It ends with a look at the specter that hangs over these engines of innovation and evidence: the fact that the pharmaceutical and biotech industries and the for-profit market for technologies have a growing impact on shaping research agendas and thus on shaping treatments.

This content is only available as PDF.
You do not currently have access to this chapter.
Don't already have an account? Register
Close Modal

or Create an Account

Close Modal
Close Modal